The year 1882 was an annus mirabilis in the history of pulmonary tuberculosis, for it saw not only the discovery of the tubercle bacillus by Robert Koch but also the introduction of artificial pneumothorax treatment by Carlo Forlanini. At that time Koch's spectacular achievements and the exaggerated expectations raised after the introduction of tuberculin tended to overshadow the significance of Forlanini's contribution to the management of pulmonary tuberculosis. In modem times drug treatment has eclipsed the former methods of collapse therapy, but for some 40 years before the introduction of antituberculous drugs artificial pneumothorax offered hope and in many cases cure to tuberculous patients around the world.
The centenary of the start of Forlaninis pioneer work on collapse therapy in pulmonary tuberculosis provides a suitable occasion to pay tribute to this great Italian phthisiologist (fig 1) .
Life of Carlo Forlanini
Carlo Forlanini was born on 11 June 1847 in Milan, the son of a physician, Giuseppe Forlanini. Carlo was the eldest of a family of four brothers and one sister. As a lad he often accompanied his father on his rounds; he was initially undecided whether to embark on a career in engineering or medicine but finally decided on the latter. His medical studies at Pavia were temporarily interrupted in 1866 when he volunteered to serve under Garibaldi. A close friend in his student days was Camillo Golgi , who was later to achieve eminence as a histologist and received the Nobel Prize in 1906. Forlanini graduated MD Pavia in 1870 with a thesis, Con- tribuzione alla Teoria della Piogenesi.
After qualification Forlanini was at first attracted towards the specialty of ophthalmology and in 1871 published a paper on inflammation of the lens-"Studio sperimentale sulla inflammazione del cris- Aerotherapy consisted essentially of the administration of compressed air for help in cardiorespiratory disorders. The theoretical basis of the treatment was to improve blood oxygenation, and the modification of intestinal gas pressure was also claimed to lower the level of the diaphragm with beneficial effect on cardiopulmonary function. Forlanini was cautious in using the treatment in pulmonary tuberculosis, especially in pyrexial cases, but these early experiences with aerotherapy were the prelude to his later researches into collapse therapy for pulmonary tuberculosis.
Collapse therapy before Forlanini
That a pneumothorax might assist the healing of a tuberculous lung was first suggested in 1771 by Edmond Claud Bourru (1737 Bourru ( -1823 It was, however, the Liverpool physicianphysiologist James Carson (1772-1843) who in 1822 first applied himself seriously to the problem and showed, in experiments on rabbits, that incision of the chest wall resulted in a pneumothorax and collapse of the lung without appreciable interference with the rabbit's activities. Recognising that "consumption crops the flower of the human race," Carson thought that an attempt at producing an artificial pneumothorax in the human was justified, although he recognised the potential risk of complete collapse of the diseased lung (Lesions of the Lung, 1822).
On 26 September 1822 Carson persuaded a Liverpool surgical colleague, Mr Henry Bickersteth, to produce a pneumothorax in two tuberculous patients. The incision through the parietal pleura failed, however, to produce a pneumothorax because of pleural adhesions. After this abortive attempt the idea of collapse therapy fell into oblivion.
There were occasional reports later of the observed beneficial effect of the development of a pneumothorax or hydropneumothorax on the course of phthisis (James Houghton, 1832; David McRuer, 1835; Walter Hayle Walshe, 1860 There were further developments in France. Claud Potain introduced sterilised air into the pleura to replace aspirated fluid and considered that keeping the lung collapsed in this fashion benefited the phthisical patient. Potain's pupil Emile Toussaint, in his thesis for the MD Paris (1880), described the beneficial effect of spontaneous pneumothorax in 24 cases of phthisis, but he did not advocate producing a pneumothorax artificially as a therapeutic measure. Toussaint's publication was followed by two similar case reports by Herard (1881) (fig 4) , although it was not until six years later that he reported the first results of the method, at the 11th International Medical Congress in Rome. In the last but one paper on the programme, he described two cases of advanced phthisis cured by artificial pneumothorax. Forlanini used a closed method of administering nitrogen (he used this gas because its absorption was slower than that of oxygen) via a large hypodermic needle. Initially 200-250 ml nitrogen was introduced; it was then given on alternate days and eventually at intervals of one week or longer. These findings were later reported in the Gazzeua Medica di Torino (1894) The pleura bears the presence of air well, any reaction or irritation or any harmful influence cannot be observed. Oxygen was more quickly absorbed than nitrogen which is now used to produce pneumothorax.
The operation must be slowly and gradually performed, each day a small quantity of nitrogen introduced; if it be absorbed the quantity must be increased. The absorptive capacity of the pleura lessens as time goes on. After some months the interval between injections can be lengthened."
In the following year, 1895 artificial pneumothorax in a German journal by Brauer (1906) , who ascribed the method to the American surgeon JB Murphy, forced Forlanini to stake his claim for priority and to do so in a German journal.
The story of the part played by the great Chicago surgeon John Benjamin Murphy nini and presumably was unaware that this treatment had preoccupied Forlanini during the previous 16 years. In performing artificial pneumothorax Murphy incised the skin and muscle and, through the apparatus which he had himself designed, he introduced nitrogen in much larger quantities (1000-3000 ml), further refills being equally large although -infrequent. Roentgen had discovered x-rays in 1895, and Murphy's 1898 paper was the first to describe x-ray control of artificial pneumothorax. Of the seven cases which Murphy reported, cure was claimed in five, although his follow-up was quite inadequate. Murphy did not subsequently carry out any further artificial pneumothorax treatment, which he considered sufficiently simple to be performed by a physician! Murphy's assistant, August Lemke, later reported on a series of cases (1899) but the method was not generally adopted in the United States at that time.
Murphy's method of artificial pneumothorax was, however, taken up in Germany. Ludolph Brauer of Marburg used the method for treating a series of tuberculous patients and when he published his findings (1905-06) he described it as Nach Murphy, which suggested that Murphy had been the originator of the method. It was this which stimulated Forlanini to write his 1906 report (and have it published in a German journal) to contradict the idea that Murphy had introduced the treatment and to establish priority for his invention. Forlanini was also opposed to Murphy's version of the treatment, in which open incision was used and very large volumes of gas were introduced intrapleurally, with resultant overcompression of the lung.
There can be no doubt that it is Forlanini to whom credit must be given for the introduction of artificial pneumothorax treatment of pulmonary tuberculosis. The timing of the invention was probably determined by several factors. Firstly, Robert Koch had announced the discovery of the tubercle bacillus at the meeting of the Berlin Physiological Society on 22 March 1882, the report of which was published three weeks later. Koch After 1912 artificial pneumothorax came to be widely adopted in Europe and the United States. There were many improvements of the original apparatus and technique. Only brief mention will be made here of the introduction of the water manometer by Christian Saugman (1906) ; the concept of partial collapse (or relaxation) of the lung and therefore the possibility of bilateral artificial pneumothorax therapy, advocated by Maurizio Ascoli (1912) ; and thoracoscopy and cauterisation of adhesions, introduced by Hans Christian Jacobaeus (1913) . All these developments and many more served to increase the success rate of the treatment.
The Carlo Forlanini Institute, Rome When Forlanini died in 1918, he had the satisfaction of knowing that his ideas on collapse therapy had been adopted throughout the world. His many pupils and admirers, both Italian and foreign, wished to create a suitable living memorial to the master. A research fund for the study of tuberculosis was founded in his name shortly after his death. Chiefly through the inspiration of his favourite pupil, Eugenio Morelli (1881 Morelli ( -1968 , the Carlo Forlanini Institute in Rome was founded in 1934.
Morelli was the first director (1934) (1935) (1936) (1937) (1938) (1939) (1940) (1941) (1942) (1943) (1944) (1945) and he was succeeded by his pupil Attilio Omedei-Zonini , who was followed by a series of distinguished Italian phthisiologists. The institute now comprises a complex of sanatorium, university clinic, laboratories, museum, and research centre. Both tuberculous and non-tuberculous diseases of the chest are handled at the institute, which remains a major Italian centre for the study of diseases of the chest, and constitutes a fitting memorial to the great Carlo Forlanini.
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